These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 36563023)
1. CD3 high and FoxP3 - tumor-infiltrating lymphocytes in the invasive margin as a favorable prognostic marker in patients with invasive urothelial carcinoma of the bladder. Sun ZJ; Zhao JW; Zhao M; Chen Y; Zhang X; Li HC; Wu GQ; Zhang DH Anticancer Drugs; 2023 Aug; 34(7):844-851. PubMed ID: 36563023 [TBL] [Abstract][Full Text] [Related]
2. The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer. Li J; Wang J; Chen R; Bai Y; Lu X Oncotarget; 2017 Feb; 8(9):15621-15631. PubMed ID: 28152503 [TBL] [Abstract][Full Text] [Related]
3. Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study. Romagnoli G; Wiedermann M; Hübner F; Wenners A; Mathiak M; Röcken C; Maass N; Klapper W; Alkatout I Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885584 [TBL] [Abstract][Full Text] [Related]
4. The presence of tumour-infiltrating lymphocytes (TILs) and the ratios between different subsets serve as prognostic factors in advanced hypopharyngeal squamous cell carcinoma. Wang J; Tian S; Sun J; Zhang J; Lin L; Hu C BMC Cancer; 2020 Aug; 20(1):731. PubMed ID: 32758195 [TBL] [Abstract][Full Text] [Related]
5. The prognostic value of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a systematic review and meta-analysis. Zhao Y; Ge X; He J; Cheng Y; Wang Z; Wang J; Sun L World J Surg Oncol; 2019 May; 17(1):85. PubMed ID: 31118034 [TBL] [Abstract][Full Text] [Related]
6. Immunochemistry-based quantification of tumor-infiltrating lymphocytes and immunoscore as prognostic biomarkers in bladder cancer. Rejeb SB; Elfekih S; Kouki N; Boulma R; Khouni H J Egypt Natl Canc Inst; 2024 Mar; 36(1):9. PubMed ID: 38523233 [TBL] [Abstract][Full Text] [Related]
7. Infiltration of CD3⁺ and CD68⁺ cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors. Sjödahl G; Lövgren K; Lauss M; Chebil G; Patschan O; Gudjonsson S; Månsson W; Fernö M; Leandersson K; Lindgren D; Liedberg F; Höglund M Urol Oncol; 2014 Aug; 32(6):791-7. PubMed ID: 24794251 [TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Tumor Infiltrating Lymphocytes in Nasopharyngeal Carcinoma Patients: Meta-Analysis. Berele BA; Cai Y; Yang G Technol Cancer Res Treat; 2021; 20():15330338211034265. PubMed ID: 34323154 [TBL] [Abstract][Full Text] [Related]
9. Importance of CD45RO+ tumor-infiltrating lymphocytes in post-operative survival of breast cancer patients. Ahmadvand S; Faghih Z; Montazer M; Safaei A; Mokhtari M; Jafari P; Talei AR; Tahmasebi S; Ghaderi A Cell Oncol (Dordr); 2019 Jun; 42(3):343-356. PubMed ID: 30825183 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of immunoscore related markers in bladder cancer. Ariafar A; Sanati A; Ahmadvand S; Shekarkhar G; Safaei A; Shayan Z; Faghih Z BMC Urol; 2022 Aug; 22(1):133. PubMed ID: 36038861 [TBL] [Abstract][Full Text] [Related]
11. Prognostic Role of Tumor-Infiltrating Lymphocytes in Esophagus Cancer: a Meta-Analysis. Zheng X; Song X; Shao Y; Xu B; Hu W; Zhou Q; Chen L; Zhang D; Wu C; Jiang J Cell Physiol Biochem; 2018; 45(2):720-732. PubMed ID: 29414812 [TBL] [Abstract][Full Text] [Related]
12. Presence of lymphocytic infiltrate cytotoxic T lymphocyte CD3+, CD8+, and immunoscore as prognostic marker in patients after radical cystectomy. Yu A; Mansure JJ; Solanki S; Siemens DR; Koti M; Dias ABT; Burnier MM; Brimo F; Kassouf W PLoS One; 2018; 13(10):e0205746. PubMed ID: 30308033 [TBL] [Abstract][Full Text] [Related]
13. The prognostic and predictive role of tumor-infiltrating lymphocytes (FoxP3 + and CD8 +) and tumor-associated macrophages in early HER2 + breast cancer. Jääskeläinen MM; Tiainen S; Siiskonen H; Ahtiainen M; Kuopio T; Rönkä A; Kettunen T; Hämäläinen K; Rilla K; Harvima I; Mannermaa A; Auvinen P Breast Cancer Res Treat; 2023 Sep; 201(2):183-192. PubMed ID: 37428418 [TBL] [Abstract][Full Text] [Related]
14. Density and location of CD3 Zhou C; Wu Y; Jiang L; Li Z; Diao P; Wang D; Zhang W; Liu L; Wang Y; Jiang H; Cheng J; Yang J J Oral Pathol Med; 2018 Apr; 47(4):359-367. PubMed ID: 29469989 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis. Gao G; Wang Z; Qu X; Zhang Z BMC Cancer; 2020 Mar; 20(1):179. PubMed ID: 32131780 [TBL] [Abstract][Full Text] [Related]
16. CD103+ Tumor Infiltrating Lymphocytes Predict a Favorable Prognosis in Urothelial Cell Carcinoma of the Bladder. Wang B; Wu S; Zeng H; Liu Z; Dong W; He W; Chen X; Dong X; Zheng L; Lin T; Huang J J Urol; 2015 Aug; 194(2):556-62. PubMed ID: 25752441 [TBL] [Abstract][Full Text] [Related]
17. Intraepithelial lymphocytes are indicators of better prognosis in surgically resected endometrioid-type endometrial carcinomas at early and advanced stages. Kono-Sato T; Miyai K; Yamagishi Y; Miyamoto M; Takano M; Matsukuma S; Sato K; Tsuda H BMC Cancer; 2022 Apr; 22(1):361. PubMed ID: 35366828 [TBL] [Abstract][Full Text] [Related]
18. The prognostic effect of tumour-infiltrating lymphocytic subpopulations in bladder cancer. Horn T; Laus J; Seitz AK; Maurer T; Schmid SC; Wolf P; Haller B; Winkler M; Retz M; Nawroth R; Gschwend JE; Kübler HR; Slotta-Huspenina J World J Urol; 2016 Feb; 34(2):181-7. PubMed ID: 26055646 [TBL] [Abstract][Full Text] [Related]
19. The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysis. Orhan A; Vogelsang RP; Andersen MB; Madsen MT; Hölmich ER; Raskov H; Gögenur I Eur J Cancer; 2020 Jun; 132():71-84. PubMed ID: 32334338 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of tumor-infiltrating lymphocytes in hepatocellular carcinoma: A meta-analysis. Ding W; Xu X; Qian Y; Xue W; Wang Y; Du J; Jin L; Tan Y Medicine (Baltimore); 2018 Dec; 97(50):e13301. PubMed ID: 30557978 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]